134 GENES FOUND

? »

Limit search: Premium | Premium (Tissue) | Premium (Subcell) | Premium (Cell line)

« prev | Page of 3 | next »

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FN1Fibronectin 1Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Expressed in all
GABBR1Gamma-aminobutyric acid (GABA) B receptor, 1FDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
GABRA1Gamma-aminobutyric acid (GABA) A receptor, alpha 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enriched
GABRA2Gamma-aminobutyric acid (GABA) A receptor, alpha 2FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Transporters
Tissue enriched
GABRA4Gamma-aminobutyric acid (GABA) A receptor, alpha 4FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Group enriched
GABRB1Gamma-aminobutyric acid (GABA) A receptor, beta 1FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Group enriched
GABREGamma-aminobutyric acid (GABA) A receptor, epsilonFDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Mixed
GABRG3Gamma-aminobutyric acid (GABA) A receptor, gamma 3FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
GABRPGamma-aminobutyric acid (GABA) A receptor, piFDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
GANABGlucosidase, alpha; neutral ABEnzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Expressed in all
GLRBGlycine receptor, betaDisease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Transporters
Tissue enhanced
GRM5Glutamate receptor, metabotropic 5FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Tissue enriched
ICAM1Intercellular adhesion molecule 1Cancer-related genes
Candidate cardiovascular disease genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
IDEInsulin-degrading enzymeEnzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Expressed in all
IFNAR1Interferon (alpha, beta and omega) receptor 1Cancer-related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
IFNGInterferon, gammaCancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
IFNGR1Interferon gamma receptor 1CD markers
Disease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
IFNGR2Interferon gamma receptor 2 (interferon gamma transducer 1)Disease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
IL11RAInterleukin 11 receptor, alphaDisease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
IL1R1Interleukin 1 receptor, type ICancer-related genes
CD markers
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
IL2RBInterleukin 2 receptor, betaCancer-related genes
CD markers
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
IL3RAInterleukin 3 receptor, alpha (low affinity)CD markers
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
ITGALIntegrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)CD markers
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
ITGB1Integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)Cancer-related genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
ITGB3Integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)Cancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
KCNN4Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
LHCGRLuteinizing hormone/choriogonadotropin receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
LIPFLipase, gastricEnzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enriched
LPLLipoprotein lipaseCandidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Group enriched
M6PRMannose-6-phosphate receptor (cation dependent)FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
METMet proto-oncogeneCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Mixed
MMP10Matrix metallopeptidase 10 (stromelysin 2)Cancer-related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enriched
MMP11Matrix metallopeptidase 11 (stromelysin 3)Cancer-related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Group enriched
MMP14Matrix metallopeptidase 14 (membrane-inserted)Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
MMP19Matrix metallopeptidase 19Disease related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enhanced
MMP2Matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
MMP21Matrix metallopeptidase 21Enzymes
FDA approved drug targets
Predicted secreted proteins
Not detected
MMP25Matrix metallopeptidase 25Enzymes
FDA approved drug targets
Predicted secreted proteins
Group enriched
MMP26Matrix metallopeptidase 26Enzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enriched
MMP3Matrix metallopeptidase 3 (stromelysin 1, progelatinase)Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
MMP7Matrix metallopeptidase 7 (matrilysin, uterine)Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
MMP8Matrix metallopeptidase 8 (neutrophil collagenase)Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
MMP9Matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
MTR5-methyltetrahydrofolate-homocysteine methyltransferaseDisease related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Expressed in all
MTTPMicrosomal triglyceride transfer proteinDisease related genes
FDA approved drug targets
Predicted secreted proteins
Group enriched
NTRK1Neurotrophic tyrosine kinase, receptor, type 1Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
PDE7APhosphodiesterase 7AEnzymes
FDA approved drug targets
Predicted secreted proteins
Expressed in all
PDGFRAPlatelet-derived growth factor receptor, alpha polypeptideCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Tissue enhanced
PDGFRBPlatelet-derived growth factor receptor, beta polypeptideCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Mixed
PGFPlacental growth factorCancer-related genes
Candidate cardiovascular disease genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
RAS pathway related proteins
Tissue enhanced

« prev | Page of 3 | next »